Clinical Trial Update: To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated whether morning versus evening dosing of fluticasone furoate 100 mcg once daily via a dry powder inhaler affects outcomes in people wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-04